Inoue T - Search Results

1

Development of ciclesonide analogues that block SARS-CoV-2 RNA replication.

Tsuji G, Yonemitsu K, Ito T, Yanase Y, Uema M, Ohoka N, Inoue T, Asakura H, Demizu Y. Tsuji G, et al. Among authors: inoue t. Bioorg Med Chem Lett. 2021 Jul 1;43:128052. doi: 10.1016/j.bmcl.2021.128052. Epub 2021 Apr 20. Bioorg Med Chem Lett. 2021. PMID: 33887440 Free PMC article.

2

Effect of the Photocatalyst under Visible Light Irradiation in SARS-CoV-2 Stability on an Abiotic Surface.

Uema M, Yonemitsu K, Momose Y, Ishii Y, Tateda K, Inoue T, Asakura H. Uema M, et al. Among authors: inoue t. Biocontrol Sci. 2021;26(2):119-125. doi: 10.4265/bio.26.119. Biocontrol Sci. 2021. PMID: 34092715 Free article.

3

Development of Agonist-Based PROTACs Targeting Liver X Receptor.

Xu H, Ohoka N, Yokoo H, Nemoto K, Ohtsuki T, Matsufuji H, Naito M, Inoue T, Tsuji G, Demizu Y. Xu H, et al. Among authors: inoue t. Front Chem. 2021 May 26;9:674967. doi: 10.3389/fchem.2021.674967. eCollection 2021. Front Chem. 2021. PMID: 34124002 Free PMC article.

4

Peptide Stapling Improves the Sustainability of a Peptide-Based Chimeric Molecule That Induces Targeted Protein Degradation.

Yokoo H, Ohoka N, Takyo M, Ito T, Tsuchiya K, Kurohara T, Fukuhara K, Inoue T, Naito M, Demizu Y. Yokoo H, et al. Among authors: inoue t. Int J Mol Sci. 2021 Aug 16;22(16):8772. doi: 10.3390/ijms22168772. Int J Mol Sci. 2021. PMID: 34445478 Free PMC article.

5

Development of Chimeric Molecules That Degrade the Estrogen Receptor Using Decoy Oligonucleotide Ligands.

Naganuma M, Ohoka N, Tsuji G, Tsujimura H, Matsuno K, Inoue T, Naito M, Demizu Y. Naganuma M, et al. Among authors: inoue t. ACS Med Chem Lett. 2021 Dec 17;13(1):134-139. doi: 10.1021/acsmedchemlett.1c00629. eCollection 2022 Jan 13. ACS Med Chem Lett. 2021. PMID: 35059133 Free PMC article.

6

Development of a potent small-molecule degrader against oncogenic BRAF^V600E protein that evades paradoxical MAPK activation.

Ohoka N, Suzuki M, Uchida T, Tsukumo Y, Yoshida M, Inoue T, Ohki H, Naito M. Ohoka N, et al. Among authors: inoue t. Cancer Sci. 2022 Aug;113(8):2828-2838. doi: 10.1111/cas.15401. Epub 2022 Jun 5. Cancer Sci. 2022. PMID: 35579105 Free PMC article.

7

Antiviral activity of ciclesonide acetal derivatives blocking SARS-CoV-2 RNA replication.

Tsuji G, Nakajima S, Watashi K, Torii S, Suzuki R, Fukuhara T, Ohoka N, Inoue T, Demizu Y. Tsuji G, et al. Among authors: inoue t. J Pharmacol Sci. 2022 Jul;149(3):81-84. doi: 10.1016/j.jphs.2022.04.001. Epub 2022 Apr 18. J Pharmacol Sci. 2022. PMID: 35641031 Free PMC article.

8

Development of Rapid and Facile Solid-Phase Synthesis of PROTACs via a Variety of Binding Styles.

Xu H, Kurohara T, Takano R, Yokoo H, Shibata N, Ohoka N, Inoue T, Naito M, Demizu Y. Xu H, et al. Among authors: inoue t. ChemistryOpen. 2022 Jul;11(7):e202200131. doi: 10.1002/open.202200131. ChemistryOpen. 2022. PMID: 35822913 Free PMC article.

9

Development of Gilteritinib-Based Chimeric Small Molecules that Potently Induce Degradation of FLT3-ITD Protein.

Ohoka N, Suzuki M, Uchida T, Tsuji G, Tsukumo Y, Yoshida M, Inoue T, Demizu Y, Ohki H, Naito M. Ohoka N, et al. Among authors: inoue t. ACS Med Chem Lett. 2022 Nov 4;13(12):1885-1891. doi: 10.1021/acsmedchemlett.2c00402. eCollection 2022 Dec 8. ACS Med Chem Lett. 2022. PMID: 36518702 Free PMC article.

10

Development of versatile solid-phase methods for syntheses of PROTACs with diverse E3 ligands.

Xu H, Kurohara T, Ohoka N, Tsuji G, Inoue T, Naito M, Demizu Y. Xu H, et al. Among authors: inoue t. Bioorg Med Chem. 2023 May 15;86:117293. doi: 10.1016/j.bmc.2023.117293. Epub 2023 Apr 25. Bioorg Med Chem. 2023. PMID: 37126968

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,895 results

Search Page

Filters